中国病案
中國病案
중국병안
CHINESE MEDICAL RECORD
2013年
4期
62-63
,共2页
苗莉%徐援*%王广%陈哲%宁志伟%杨宁%姚志%高霞
苗莉%徐援*%王廣%陳哲%寧誌偉%楊寧%姚誌%高霞
묘리%서원*%왕엄%진철%저지위%양저%요지%고하
2型糖尿病%良性前列腺增生%血糖%体重%胰岛素抵抗
2型糖尿病%良性前列腺增生%血糖%體重%胰島素牴抗
2형당뇨병%량성전렬선증생%혈당%체중%이도소저항
Type 2 diabetes%Benign prostatic hyperplasia%Blood glucose%Weight%Insulin resistance
目的探讨2型糖尿病(DM )中良性前列腺增生(BPH)与体重、血糖、胰岛素抵抗等代谢指标的关系.方法对244例DM患者按是否合并BPH分为两组,将其临床资料进行对比.结果 BPH组与非BNP组相比在年龄(68.46±13.78 vs 62.11±11.03)、体重指数(BMI)(27.3±2.7 vs 25.4±2.4)、空腹血糖(FPG)(7.78±2.37 vs 6.83±2.49)、糖化血红蛋白(HbA1C)(7.72±2.11 vs 6,93±1.67)等方面都存在显著性差异( P<0.05).结论2型糖尿病患者中肥胖、高血糖促进BPH的进展.
目的探討2型糖尿病(DM )中良性前列腺增生(BPH)與體重、血糖、胰島素牴抗等代謝指標的關繫.方法對244例DM患者按是否閤併BPH分為兩組,將其臨床資料進行對比.結果 BPH組與非BNP組相比在年齡(68.46±13.78 vs 62.11±11.03)、體重指數(BMI)(27.3±2.7 vs 25.4±2.4)、空腹血糖(FPG)(7.78±2.37 vs 6.83±2.49)、糖化血紅蛋白(HbA1C)(7.72±2.11 vs 6,93±1.67)等方麵都存在顯著性差異( P<0.05).結論2型糖尿病患者中肥胖、高血糖促進BPH的進展.
목적탐토2형당뇨병(DM )중량성전렬선증생(BPH)여체중、혈당、이도소저항등대사지표적관계.방법대244례DM환자안시부합병BPH분위량조,장기림상자료진행대비.결과 BPH조여비BNP조상비재년령(68.46±13.78 vs 62.11±11.03)、체중지수(BMI)(27.3±2.7 vs 25.4±2.4)、공복혈당(FPG)(7.78±2.37 vs 6.83±2.49)、당화혈홍단백(HbA1C)(7.72±2.11 vs 6,93±1.67)등방면도존재현저성차이( P<0.05).결론2형당뇨병환자중비반、고혈당촉진BPH적진전.
@@@@Objective To investigate the relationship between the metabolic indexes of type 2 diabetes ,such as benign prostatic hyperplasia ,weight ,blood glucose and insulin resistance ,Methods 244 cases of DM patients were divided into two groups according to whether the merger of BPH ,and made a comparison of their clinical data .Results Compared with BPH group ,the non-BPH group has significant differences (P<0 .05)in aspects such as age(68 .46 ± 13 .78 vs 62 .11 ± 11 .03 ,body mass index (BMI)(27 .3 ± 2 .7 vs 25 .4 ± 2 .4 ,fasting blood glucose(FBG)(7 .78 ± 2 .37 vs 6 .83 ± 2 .49 ,glycated hemoglobin ,(HbA1C)(7 .72 ± 2 .11 vs 6 ,93 ± 1 . 67) .Conclusion In type 2 diabetes ,high blood glucose and obesity can promote the progress of BPH .
